Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4849060
Max Phase: Preclinical
Molecular Formula: C52H60N6O6
Molecular Weight: 865.09
Molecule Type: Unknown
Associated Items:
ID: ALA4849060
Max Phase: Preclinical
Molecular Formula: C52H60N6O6
Molecular Weight: 865.09
Molecule Type: Unknown
Associated Items:
Canonical SMILES: O=C(CCCCCCCCC(=O)Nc1ccc2c(c1)[C@@]13CCN4CC5=CCO[C@H]6CC(=O)N2[C@H]1[C@H]6[C@H]5C[C@H]43)Nc1ccc2c(c1)[C@@]13CCN4CC5=CCO[C@H]6CC(=O)N2[C@H]1[C@H]6[C@H]5C[C@H]43
Standard InChI: InChI=1S/C52H60N6O6/c59-43(53-31-9-11-37-35(21-31)51-15-17-55-27-29-13-19-63-39-25-45(61)57(37)49(51)47(39)33(29)23-41(51)55)7-5-3-1-2-4-6-8-44(60)54-32-10-12-38-36(22-32)52-16-18-56-28-30-14-20-64-40-26-46(62)58(38)50(52)48(40)34(30)24-42(52)56/h9-14,21-22,33-34,39-42,47-50H,1-8,15-20,23-28H2,(H,53,59)(H,54,60)/t33-,34-,39-,40-,41-,42-,47-,48-,49-,50-,51+,52+/m0/s1
Standard InChI Key: QLCSKZVXUOKPBG-UZNBVYRHSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 865.09 | Molecular Weight (Monoisotopic): 864.4574 | AlogP: 6.20 | #Rotatable Bonds: 11 |
Polar Surface Area: 123.76 | Molecular Species: BASE | HBA: 8 | HBD: 2 |
#RO5 Violations: 2 | HBA (Lipinski): 12 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 13.92 | CX Basic pKa: 9.37 | CX LogP: 3.04 | CX LogD: -0.30 |
Aromatic Rings: 2 | Heavy Atoms: 64 | QED Weighted: 0.20 | Np Likeness Score: 0.97 |
1. Zlotos DP, Abdelmalek CM, Botros LS, Banoub MM, Mandour YM, Breitinger U, El Nady A, Breitinger HG, Sotriffer C, Villmann C, Jensen AA, Holzgrabe U.. (2021) C-2-Linked Dimeric Strychnine Analogues as Bivalent Ligands Targeting Glycine Receptors., 84 (2.0): [PMID:33596384] [10.1021/acs.jnatprod.0c01030] |
Source(1):